{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:32:21Z","timestamp":1786365141860,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51586-9","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:54:53Z","timestamp":1780048493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The cationic nanoliposomes loaded with asymmetric PCR product targeting PTK6 mRNA and induce apoptosis in PANC-1 cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Reyhane","family":"Fooladi Vayqan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh","family":"Entezari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziye","family":"Tajali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Zali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jebali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"1","key":"51586_CR1","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1038\/s41598-022-08083-6","volume":"12","author":"T Takikawa","year":"2022","unstructured":"Takikawa, T. et al. Clinical features and prognostic impact of asymptomatic pancreatic cancer. Sci. Rep. 12 (1), 4262 (2022).","journal-title":"Sci. Rep."},{"issue":"1","key":"51586_CR2","doi-asserted-by":"publisher","first-page":"16425","DOI":"10.1038\/s41598-020-73525-y","volume":"10","author":"A Bengtsson","year":"2020","unstructured":"Bengtsson, A., Andersson, R. & Ansari, D. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data. Sci. Rep. 10 (1), 16425 (2020).","journal-title":"Sci. Rep."},{"key":"51586_CR3","doi-asserted-by":"publisher","first-page":"1002299","DOI":"10.37349\/etat.2025.1002299","volume":"6","author":"V Cereda","year":"2025","unstructured":"Cereda, V. & D\u2019Andrea, M. R. Pancreatic cancer: failures and hopes\u2014a review of new promising treatment approaches. Explor. Target. Anti-tumor Therapy. 6, 1002299 (2025).","journal-title":"Explor. Target. Anti-tumor Therapy"},{"issue":"1","key":"51586_CR4","first-page":"5160705","volume":"2022","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Comprehensive analysis reveals PTK6 as a prognostic biomarker involved in the immunosuppressive microenvironment in breast Cancer. J. Immunol. Res. 2022 (1), 5160705 (2022).","journal-title":"J. Immunol. Res."},{"issue":"1","key":"51586_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12905-023-02736-y","volume":"23","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Qu, W., Tu, J., Yang, L. & Gui, X. Prognostic impact of PTK6 expression in triple negative breast cancer. BMC Women\u2019s Health. 23 (1), 575 (2023).","journal-title":"BMC Women\u2019s Health"},{"key":"51586_CR6","unstructured":"Alwanian, W. M. The Role of Protein Tyrosine Kinase 6 in Prostate Cancer Progression (University of Illinois at Chicago, 2022)."},{"issue":"6","key":"51586_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1158\/1541-7786.MCR-15-0450","volume":"14","author":"PS Mathur","year":"2016","unstructured":"Mathur, P. S. et al. Kinase-dependent and-independent roles for PTK6 in colon cancer. Mol. Cancer Res. 14 (6), 563\u2013573 (2016).","journal-title":"Mol. Cancer Res."},{"key":"51586_CR8","doi-asserted-by":"crossref","unstructured":"Zhao, C. et al. Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance. OncoTargets therapy :183\u2013188. (2013).","DOI":"10.2147\/OTT.S41283"},{"issue":"5","key":"51586_CR9","doi-asserted-by":"publisher","first-page":"e96060","DOI":"10.1371\/journal.pone.0096060","volume":"9","author":"H Ono","year":"2014","unstructured":"Ono, H., Basson, M. D. & Ito, H. PTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling. PloS one. 9 (5), e96060 (2014).","journal-title":"PloS one"},{"issue":"2","key":"51586_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1242\/jcs.053264","volume":"123","author":"HL Palka-Hamblin","year":"2010","unstructured":"Palka-Hamblin, H. L. et al. Identification of \u03b2-catenin as a target of the intracellular tyrosine kinase PTK6. J. Cell Sci. 123 (2), 236\u2013245 (2010).","journal-title":"J. Cell Sci."},{"issue":"17","key":"51586_CR11","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1128\/MCB.00024-10","volume":"30","author":"Y Zheng","year":"2010","unstructured":"Zheng, Y., Peng, M., Wang, Z., Asara, J. M. & Tyner, A. L. Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor. Mol. Cell. Biol. 30 (17), 4280\u20134292 (2010).","journal-title":"Mol. Cell. Biol."},{"issue":"14","key":"51586_CR12","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.3390\/cancers15143703","volume":"15","author":"S Jerin","year":"2023","unstructured":"Jerin, S., Harvey, A. J. & Lewis, A. Therapeutic potential of protein tyrosine kinase 6 in colorectal cancer. Cancers 15 (14), 3703 (2023).","journal-title":"Cancers"},{"issue":"3","key":"51586_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/genes4030457","volume":"4","author":"TT Nielsen","year":"2013","unstructured":"Nielsen, T. T. & Nielsen, J. E. Antisense gene silencing: therapy for neurodegenerative disorders? Genes 4 (3), 457\u2013484 (2013).","journal-title":"Genes"},{"issue":"9","key":"51586_CR14","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.3390\/pharmaceutics15092363","volume":"15","author":"C Viegas","year":"2023","unstructured":"Viegas, C. et al. Advances in pancreatic cancer treatment by nano-based drug delivery systems. Pharmaceutics 15 (9), 2363 (2023).","journal-title":"Pharmaceutics"},{"key":"51586_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe, L. et al. Advances and challenges of liposome assisted drug delivery. Front. Pharmacol. 6, 286 (2015).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"51586_CR16","first-page":"514","volume":"24","author":"FK Tehrani","year":"2021","unstructured":"Tehrani, F. K., Ranji, N., Kouhkan, F. & Hosseinzadeh, S. PANC-1 cancer stem-like cell death with silybin encapsulated in polymersomes and deregulation of stemness-related miRNAs and their potential targets. Iran. J. Basic. Med. Sci. 24 (4), 514 (2021).","journal-title":"Iran. J. Basic. Med. Sci."},{"issue":"3","key":"51586_CR17","first-page":"157","volume":"2","author":"S Beheshti","year":"2018","unstructured":"Beheshti, S., Tohidloo, S. & Ghorbanpour-Shakakomi, A. Extraction of high quality ribonucleic acid molecules from the rat brain by means of an inexpensive method. Iran. J. Physiol. Pharmacol. 2 (3), 157\u2013152 (2018).","journal-title":"Iran. J. Physiol. Pharmacol."},{"issue":"1","key":"51586_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11033-021-06844-6","volume":"49","author":"S Hashemi","year":"2022","unstructured":"Hashemi, S. et al. The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway. Mol. Biol. Rep. 49 (1), 85\u201395 (2022).","journal-title":"Mol. Biol. Rep."},{"key":"51586_CR19","doi-asserted-by":"crossref","unstructured":"Manesh, F. K., Jebali, A. & Forouzesh, F. The targeted delivery of anti-metastasis oligonucleotide in breast cancer cells by the nanoliposomes conjugated with RGD ligand. Adv. Cancer Biology-Metastasis :100140. (2025).","DOI":"10.1016\/j.adcanc.2025.100140"},{"key":"51586_CR20","doi-asserted-by":"crossref","unstructured":"Rezaeidian, J., Naseh, V., Entezari, M., Ziyadi, H. & Hashemi, M. Curcumin Induces MCF-7 Breast Cancer Cell Apoptosis Through miR-15a Alteration. Int. J. Cancer Manage. ;17(1). (2024).","DOI":"10.5812\/ijcm-154265"},{"issue":"12","key":"51586_CR21","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41434-021-00265-7","volume":"29","author":"N Mokri","year":"2022","unstructured":"Mokri, N. et al. Chitosan-coated Zn-metal-organic framework nanocomposites for effective targeted delivery of LNA-antisense miR-224 to colon tumor: in vitro studies. Gene Ther. 29 (12), 680\u2013690 (2022).","journal-title":"Gene Ther."},{"key":"51586_CR22","doi-asserted-by":"publisher","first-page":"172426","DOI":"10.1016\/j.ejphar.2019.172426","volume":"857","author":"S Mirzaei","year":"2019","unstructured":"Mirzaei, S., Baghaei, K., Parivar, K., Hashemi, M. & Aghdaei, H. A. The expression level changes of microRNAs 200a\/205 in the development of invasive properties in gastric cancer cells through epithelial-mesenchymal transition. Eur. J. Pharmacol. 857, 172426 (2019).","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"51586_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2015.02.047","volume":"63","author":"Y Mizuguchi","year":"2015","unstructured":"Mizuguchi, Y. et al. Breast tumor kinase\/protein tyrosine kinase 6 (Brk\/PTK6) activity in normal and neoplastic biliary epithelia. J. Hepatol. 63 (2), 399\u2013407 (2015).","journal-title":"J. Hepatol."},{"issue":"3","key":"51586_CR24","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.bbrc.2018.07.051","volume":"503","author":"D Wu","year":"2018","unstructured":"Wu, D. et al. Decreased expression of protein tyrosine kinase 6 contributes to tumor progression and metastasis in laryngeal squamous cell carcinoma. Biochem. Biophys. Res. Commun. 503 (3), 1378\u20131384 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"51586_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ygyno.2020.05.059","volume":"159","author":"S Tomita","year":"2020","unstructured":"Tomita, S., Blank, S. V. & Irie, H. Therapeutic targeting of PTK6 oncogene in ovarian cancer. Gynecol. Oncol. 159, 84 (2020).","journal-title":"Gynecol. Oncol."},{"key":"51586_CR26","doi-asserted-by":"crossref","unstructured":"Yang, Y. et al. Pan-cancer comprehensive analysis: The role of important PTK family genes in cancer. (2025).","DOI":"10.21203\/rs.3.rs-6151214\/v1"},{"issue":"5","key":"51586_CR27","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2353\/ajpath.2006.050521","volume":"168","author":"M Kasprzycka","year":"2006","unstructured":"Kasprzycka, M. et al. Expression and oncogenic role of Brk (PTK6\/Sik) protein tyrosine kinase in lymphocytes. Am. J. Pathol. 168 (5), 1631\u20131641 (2006).","journal-title":"Am. J. Pathol."},{"issue":"38","key":"51586_CR28","doi-asserted-by":"publisher","first-page":"15647","DOI":"10.1039\/D4SC04782F","volume":"15","author":"Y Shi","year":"2024","unstructured":"Shi, Y. et al. Cascade-responsive size\/charge bidirectional-tunable nanodelivery penetrates pancreatic tumor barriers. Chem. Sci. 15 (38), 15647\u201315658 (2024).","journal-title":"Chem. Sci."},{"key":"51586_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.omtn.2017.07.013","volume":"8","author":"T Michel","year":"2017","unstructured":"Michel, T. et al. Cationic nanoliposomes meet mRNA: Efficient delivery of modified mRNA using hemocompatible and stable vectors for therapeutic applications. Mol. therapy Nucleic acids. 8, 459\u2013468 (2017).","journal-title":"Mol. therapy Nucleic acids"},{"issue":"1","key":"51586_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes, B. B. et al. Nanodelivery of nucleic acids. Nat. reviews Methods primers. 2 (1), 24 (2022).","journal-title":"Nat. reviews Methods primers"},{"issue":"8","key":"51586_CR31","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/1541-7786.MCR-15-0034","volume":"13","author":"H Ono","year":"2015","unstructured":"Ono, H., Basson, M. D. & Ito, H. PTK6 potentiates gemcitabine-induced apoptosis by prolonging S-phase and enhancing DNA damage in pancreatic cancer. Mol. Cancer Res. 13 (8), 1174\u20131184 (2015).","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"51586_CR32","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1021\/mp900093r","volume":"6","author":"R Juliano","year":"2009","unstructured":"Juliano, R., Bauman, J., Kang, H. & Ming, X. Biological barriers to therapy with antisense and siRNA oligonucleotides. Mol. Pharm. 6 (3), 686\u2013695 (2009).","journal-title":"Mol. Pharm."},{"key":"51586_CR33","unstructured":"Gu, S. Nanoparticle Based RNAi Therapeutic to Overcome Intrinsic and Acquired Resistance in HER2\u2009+\u2009Breast Cancer (Oregon Health & Science University, 2018)."},{"key":"51586_CR34","doi-asserted-by":"crossref","unstructured":"Panday, A., Dixena, B., Jain, N. & Jain, A. K. Lipid-based Non-viral Vector: Promising Approach for Gene Delivery. Curr. Pharm. Design (2024).","DOI":"10.2174\/0113816128324084240828084904"},{"issue":"7","key":"51586_CR35","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1002\/mco2.583","volume":"5","author":"SN Yildiz","year":"2024","unstructured":"Yildiz, S. N. et al. Nanoliposomes as nonviral vectors in cancer gene therapy. MedComm 5 (7), e583 (2024).","journal-title":"MedComm"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51586-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51586-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51586-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:04:13Z","timestamp":1786363453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51586-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51586"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51586-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of Medical Research at Tehran Medical Sciences, Islamic Azad University, Tehran, Iran (Ethics code; IR.IAU.PS.REC.1402.158. No animals were used in this research. Also, no human subjects, human data, or human tissues were used in this study.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval of the research protocol: Not applicable.","order":3,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants for participation in the study and for publication of the results.","order":4,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24619"}}